NKX2-5 and immune system disorder: Besides, the expression of JAM3 is decreased in this progression and its defection may cause immunodeficiency in mice, which in turn reduces tumor immune surveillance [30]; in the second pathway, homeobox protein NKX2-5 upregulates target genes PAP2C and JMY, which can lead to cancer cell apoptosis.